<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>We read with great interest the European trial of <z:chebi fb="0" ids="4031">cyclosporine</z:chebi> alone versus antithymocyte globulin (ATG) and cyclosporin together for the treatment of patients with nonsevere <z:hpo ids='HP_0001915'>aplastic anemia</z:hpo>.1 </plain></SENT>
</text></document>